Have you evaluated the performance of Phibro Animal Health's (PAHC) international operations for the quarter ending September 2024? Given the extensive global presence of this maker of animal health products and nutritional supplements, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth.The global economy today is deeply interlinked, making a company's engagement with international markets a critical factor in determining its financi ...

Phibro Animal Health Corporation (NASDAQ:PAHC) Q1 2025 Earnings Conference Call November 7, 2024 9:00 AM ET Company Participants Glenn David - Chief Financial Officer Jack Bendheim - Chairman-Board of Directors, President & Chief Executive Officer Daniel Bendheim - Director & Executive Vice President-Corporate Strategy Larry Miller - Chief Operating Officer Conference Call Participants Ekaterina Knyazkova - JPMorgan Michael Ryskin - Bank of America Navann Ty - BNP Paribas Operator Hello, and thank you for s ...

Phibro Animal Health Corporation Webcast and Conference Call November 7, 2024 U.S. toll-free +1.888.330.2022 International toll +1.365.977.0051 Conference ID: 3927884 Financial Results Fiscal Year 2025 First Quarter Ended September 30, 2024 November 7, 2024 Webcast and Conference Call Important Information Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties, including with respect to any future debt and ...

Phibro Animal Health (PAHC) delivered adjusted earnings per share (EPS) of 35 cents in the first quarter of fiscal 2025 compared with 14 cents in the year-ago quarter. The bottom line beat the Zacks Consensus Estimate by 52.2%.Without adjustments, the GAAP EPS in the quarter was 17 cents compared to a loss of 20 cents in the prior-year period.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Following the announcement, PAHC shares rose nearly 8% in the after-hours trading yesterday.  PA ...

Phibro Animal Health (PAHC) reported $260.4 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 12.6%. EPS of $0.35 for the same period compares to $0.14 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $277.76 million, representing a surprise of -6.25%. The company delivered an EPS surprise of +52.17%, with the consensus EPS estimate being $0.23.While investors scrutinize revenue and earnings changes year-over-year and how they compa ...

Phibro Animal Health (PAHC) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 52.17%. A quarter ago, it was expected that this maker of animal health products and nutritional supplements would post earnings of $0.34 per share when it actually produced earnings of $0.41, delivering a sur ...

Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance TEANECK, N.J., November 6, 2024 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) ("Phibro" or the "Company") today announced financial results for its first quarter ended September 30, 2024 and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended September 30, 2024 (compared to the three months ended September 30, 20 ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, $0.0001 par value per share PAHC Nasdaq Stock Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tran ...

Phibro Animal Health Corporation (PAHC) recently completed the acquisition of Zoetis Inc.’s (ZTS) medicated feed additive (MFA) product portfolio and certain water-soluble products. The latest acquisition comes with a lineup of products across cattle, swine and poultry, which will complement and expand Phibro’s species and product portfolios. This will help the company’s customers meet the highest standards of animal care, prevent diseases and enhance nutrition around the world. PAHC’s Likely Stock Trend Fo ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.It also includes access to the Zacks Style Scores.What are the Zacks Style Scores?The Zacks Style S ...